share_log

Novavax | 8-K: R&D President Filip Dubovsky Resigns

Novavax | 8-K: R&D President Filip Dubovsky Resigns

诺瓦瓦克斯医药 | 8-K:研发总裁Filip Dubovsky辞职
美股sec公告 ·  05/23 16:12
Moomoo AI 已提取核心信息
On May 20, 2024, Novavax, Inc. announced the retirement of Filip Dubovsky as President of Research and Development, effective June 30, 2024. Dubovsky will continue to provide consulting services to Novavax for 12 months post-retirement under a consulting agreement. The agreement stipulates a monthly consulting fee of $15,000 and payment of COBRA premiums for up to 11 months. Dubovsky's equity awards will vest during the consulting period, and any unexercised stock options will remain exercisable for 90 days after the consulting period ends. The agreement allows for termination by either party with 30 days' notice. The terms of Dubovsky's non-competition and non-solicitation covenants will begin post-retirement. Details of the consulting agreement will be included in Novavax's Quarterly Report on Form 10-Q for the quarter ending June 30, 2024.
On May 20, 2024, Novavax, Inc. announced the retirement of Filip Dubovsky as President of Research and Development, effective June 30, 2024. Dubovsky will continue to provide consulting services to Novavax for 12 months post-retirement under a consulting agreement. The agreement stipulates a monthly consulting fee of $15,000 and payment of COBRA premiums for up to 11 months. Dubovsky's equity awards will vest during the consulting period, and any unexercised stock options will remain exercisable for 90 days after the consulting period ends. The agreement allows for termination by either party with 30 days' notice. The terms of Dubovsky's non-competition and non-solicitation covenants will begin post-retirement. Details of the consulting agreement will be included in Novavax's Quarterly Report on Form 10-Q for the quarter ending June 30, 2024.
2024年5月20日,Novavax, Inc.宣布菲利普·杜波夫斯基退休研发总裁一职,自2024年6月30日起生效。根据咨询协议,杜波夫斯基将在退休后的12个月内继续向Novavax提供咨询服务。该协议规定每月咨询费为15,000美元,并支付长达11个月的COBRA保费。杜波夫斯基的股权奖励将在咨询期内归属,任何未行使的股票期权将在咨询期结束后的90天内继续行使。该协议允许任何一方在提前30天通知的情况下终止。杜波夫斯基的禁止竞争和不招揽契约的条款将在退休后生效。咨询协议的详细信息将包含在Novavax截至2024年6月30日的季度10-Q表季度报告中。
2024年5月20日,Novavax, Inc.宣布菲利普·杜波夫斯基退休研发总裁一职,自2024年6月30日起生效。根据咨询协议,杜波夫斯基将在退休后的12个月内继续向Novavax提供咨询服务。该协议规定每月咨询费为15,000美元,并支付长达11个月的COBRA保费。杜波夫斯基的股权奖励将在咨询期内归属,任何未行使的股票期权将在咨询期结束后的90天内继续行使。该协议允许任何一方在提前30天通知的情况下终止。杜波夫斯基的禁止竞争和不招揽契约的条款将在退休后生效。咨询协议的详细信息将包含在Novavax截至2024年6月30日的季度10-Q表季度报告中。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息